How Does The NeuBase Therapeutics (NBSE) Stock Price Decrease In Pre-Market Session?
Shares of NeuBase Therapeutics Inc. (NBSE) were down -19.55% as of the most recent check, trading at $0.2333 in pre-market. The decline occurred in the absence of any major news, yet it was the catalyst for the recent session’s 20% increase in the NBSE stock. What current events took place at NBSE? A research partnership […]
